SII, Gavi and BMGF collaborate for COVID-19 vaccines, SII to price per vaccine dose at Rs 225
Serum Institute of India to produce up to 100 million COVID-19 vaccine doses which will be made available to the 92 countries…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
DBT
DBT seed funds Gennova Biopharmaceuticals’ novel mRNA-based COVID-19 vaccine candidate
The clinical trials for the vaccine are likely to start before the year ends
Indian pharma industry can produce COVID-19 vaccines for entire world: Bill Gates
Highlighting Gates Foundation's role in India’s war against coronavirus, he said that it has been funding work on detection and…
DBT establishes four COVID-19 bio banks
Oropharyngeal/nasopharyngeal swabs, bronchoalveolar lavage, sputum, blood, urine and stool of COVID19 patients will be collected…
DBT facilitates rapid response regulatory enabling mechanism for COVID-19
Aims to streamline and ease development of vaccines, diagnostics, prophylactics and therapeutics
High-level panel to recommend reforms in India’s drug regulations
The panel, chaired by Rajesh Bhushan, the OSD to the Union Health Minister, comprises top drug and vaccine entrepreneurs as well…
DBT invites LoI to set up Virtual Network Centers in cancer immunology and immunotherapy
Calls on scientists and researchers to create a centralised platform and work together to develop and actualise a cancer research…
DBT-BIRAC COVID-19 research consortium recommends 70 proposals for funding in vaccines, diagnostics,…
The shortlisted proposals includes10 vaccines candidates, 34 diagnostics products or scale-up facilities, 10 therapeutics options,…
DBT and BIRAC recommend 16 proposals for funding support towards COVID-19 Research Consortium
The duo received around 500 applications from academia and industry
Government forms high-level task force for COVID-19-related works
The task force will ensure work progress in the fields of science and vaccine development